We are live on ! Find out more
CRL icon

Charles River Laboratories
CRL

644 hedge funds and large institutions have $13.5B invested in Charles River Laboratories in 2022 Q1 according to their latest regulatory filings, with 60 funds opening new positions, 262 increasing their positions, 235 reducing their positions, and 115 closing their positions.

New
Increased
Maintained
Reduced
Closed

11% more repeat investments, than reductions

Existing positions increased: 262 | Existing positions reduced: 235

0.8% more ownership

Funds ownership: 93.47% → 94.28% (+0.8%)

1% less call options, than puts

Call options by funds: $77.7M | Put options by funds: $78.4M

9% less funds holding

Funds holding: 707 → 644 (-63)

24% less capital invested

Capital invested by funds: $17.7B → $13.5B (-$4.23B)

48% less first-time investments, than exits

New positions opened: 60 | Existing positions closed: 115

53% less funds holding in top 10

Funds holding in top 10: 15 → 7 (-8)

Holders
644
Holders Change
-63
Holders Change %
-8.91%
% of All Funds
10.16%
Holding in Top 10
7
Holding in Top 10 Change
-8
Holding in Top 10 Change %
-53.33%
% of All Funds
0.11%
New
60
Increased
262
Reduced
235
Closed
115
Calls
$77.7M
Puts
$78.4M
Net Calls
-$664K
Net Calls Change
-$48.1M

Top Buyers

1
Mackenzie Financial
Mackenzie Financial
Ontario, Canada
+$171M
2
ClearBridge Investments
ClearBridge Investments
New York
+$92.9M
3
Fidelity International
Fidelity International
Bermuda
+$83.3M
4
Two Sigma Investments
Two Sigma Investments
New York
+$53.3M
5
JMPWA
JP Morgan Private Wealth Advisors
California
+$47M

Top Sellers

1
Invesco
Invesco
Georgia
-$142M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$118M
3
Brown Advisory
Brown Advisory
Maryland
-$111M
4
Marshall Wace
Marshall Wace
United Kingdom
-$86.9M
5
ESCM
Echo Street Capital Management
New York
-$65.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
Squarepoint
101
Squarepoint
New York
$17.6M +$15.1M +48,948 +375%
TCM
102
Tekla Capital Management
Massachusetts
$17.6M – – –
MAM
103
Martingale Asset Management
Massachusetts
$17.5M -$2.03M -6,586 -10%
State Board of Administration of Florida Retirement System
104
State Board of Administration of Florida Retirement System
Florida
$16.8M -$617K -2,000 -3%
CS
105
Credit Suisse
Switzerland
$16.3M -$359K -1,164 -2%
VanEck Associates
106
VanEck Associates
New York
$16.1M +$78K +253 +0.4%
FLPIM
107
F.L. Putnam Investment Management
Massachusetts
$16M -$3.93M -12,749 -18%
CSS
108
Cubist Systematic Strategies
Connecticut
$15.8M +$15.8M +51,204 +1,155%
THP
109
Tower House Partners
United Kingdom
$15.6M -$10.5M -33,925 -38%
UBS Group
110
UBS Group
Switzerland
$14.9M -$8.54M -27,695 -35%
Prudential Financial
111
Prudential Financial
New Jersey
$14.7M +$453K +1,468 +3%
LIC
112
Laurus Investment Counsel
Canada
$14.6M +$75.5K +245 +0.5%
PI
113
PineBridge Investments
New York
$14.5M +$7.48M +24,267 +90%
CWM
114
Congress Wealth Management
Massachusetts
$14.5M +$224K +726 +1%
NC
115
Nicholas Company
Wisconsin
$14.4M -$279K -904 -2%
KCM
116
Kingdon Capital Management
New York
$14.3M +$15.5M +50,200 New
Osaic Holdings
117
Osaic Holdings
Arizona
$14.2M -$1.2M -3,900 -9%
Thrivent Financial for Lutherans
118
Thrivent Financial for Lutherans
Minnesota
$14.2M -$12M -38,917 -44%
National Bank of Canada
119
National Bank of Canada
Quebec, Canada
$13.8M +$13.7M +44,519 +2,264%
KPCM
120
Kings Point Capital Management
New York
$13.8M +$505K +1,639 +4%
CCM
121
Channing Capital Management
Illinois
$13.8M +$5.04M +16,355 +51%
Public Employees Retirement Association of Colorado
122
Public Employees Retirement Association of Colorado
Colorado
$13.5M -$682K -2,211 -4%
HSBC Holdings
123
HSBC Holdings
United Kingdom
$13.1M +$451K +1,463 +3%
N
124
Natixis
France
$13M +$9.39M +30,439 +201%
Walleye Capital
125
Walleye Capital
New York
$12.6M +$4.21M +13,642 +44%
3 4
5
6 7

CRL Hedge Fund Activity: Q1 2022 in Review

644 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Charles River Laboratories (CRL) for Q1 2022, worth a combined $13.5B — down 24% from $17.7B a quarter earlier.

Sellers outnumbered buyers: 115 funds closed out of CRL and 60 opened new positions — a net loss of 55 holders — while 235 trimmed existing stakes and 262 added.

The largest buyer was Mackenzie Financial, adding an estimated $171M. The largest seller was Invesco, cutting an estimated $142M.

  • 644 institutional investors held Charles River Laboratories (CRL) as of Q1 2022, down from 707 in Q4 2021.
  • Funds reported $13.5B of Charles River Laboratories stock for Q1 2022, down 24% quarter-over-quarter.
  • 60 funds opened new Charles River Laboratories positions in Q1 2022 and 115 closed out, a net change of -55 holders.
  • The largest Charles River Laboratories buyer in Q1 2022 was Mackenzie Financial, an estimated $171M added.
  • The largest Charles River Laboratories seller in Q1 2022 was Invesco, an estimated $142M sold.

Based on aggregated 13F filings for Q1 2022.